NBIX - Neurocrine Biosciences Inc. (NBIX) CEO Kevin Gorman on Q2 2021 Results - Earnings Call Transcript
Neurocrine Biosciences, Inc. (NBIX) Q2 2021 Results Conference Call August 03, 2021 04:30 PM ET Company Participants Todd Tushla - VP, IR Kevin Gorman - CEO Matt Abernethy - CFO Eiry Roberts - Chief Medical Officer Eric Benevich - Chief Commercial Officer Kyle Gano - Chief Business Development and Strategy Officer Conference Call Participants Tazeen Ahmad - Bank of America Phil Nadeau - The Cowen Company Paul Matteis - Stifel Brian Abrahams - RBC Capital Markets Brian Skorney - Baird Jay Olson - Oppenheimer Neena Bitritto-Garg - Citi Anupam Rama - JP Morgan David Amsellem - Piper Sandler Chris Shibutani - Goldman Sachs Charles Duncan - Cantor Fitzgerald Vamil Divan - Mizuho Josh Schimmer - Evercore Myles Minter - William Blair Danielle Brill - Raymond James Laura Chico - Wedbush Securities Eddie Hickman - Guggenheim Presentation Operator Good day, everyone, and welcome to today’s Neurocrine Biosciences Reports Second Quarter Results.
For further details see:
Neurocrine Biosciences, Inc. (NBIX) CEO Kevin Gorman on Q2 2021 Results - Earnings Call Transcript